Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. [electronic resource]
- Journal of the National Cancer Institute Aug 2009
- 1083-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1460-2105
10.1093/jnci/djp183 doi
Adult Cost-Benefit Analysis Drug Costs Female Humans Middle Aged Netherlands--epidemiology Papillomavirus Infections--complications Papillomavirus Vaccines--administration & dosage Quality-Adjusted Life Years Tumor Virus Infections--complications Uterine Cervical Neoplasms--economics